The global Osteoporosis Treatment Market, valued at USD 13.28 billion in 2023, is anticipated to experience substantial growth, reaching an estimated USD 18.59 billion by 2031. This projection represents a compound annual growth rate (CAGR) of 4.3% over the forecast period from 2024 to 2031. Key Players The major key players are AbbVie Inc., Eli Lilly and Company, Amgen Inc.,...